The COVID-19 pandemic has upended lives and plans. Jobs have been lost and families are struggling. Retirement savings have diminished. Businesses are closing, and the American Cancer Society is no exception with projected revenue for 2020 has declined by one third.
Despite deep and painful cuts we have made, American Cancer Society programs, including our hallmark research program, are in jeopardy. Each year, we invest $100 million in new research. Because of the budget shortfall, we are at risk of cutting cancer research funding by 50 percent this year -- this would represent our lowest investment in this century.
Failing to invest in research now means that we will have fewer preventative tools, fewer treatment options, lost progress towards a cure, and ultimately, more deaths from cancer in the future.
Will you join us in our ambitious effort to raise $100 million towards cancer research?